首页> 外文期刊>Archives of medical research >Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor.
【24h】

Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor.

机译:异位促肾上腺皮质激素分泌综合征:单中心经验报告,隐匿性肿瘤高发。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Differentiation between the two forms of ACTH-dependent Cushing's syndrome is a challenging task. Although the majority of these cases will be diagnosed as Cushing's disease secondary to an ACTH-secreting pituitary adenoma, 10-15% result from the ectopic ACTH secretion syndrome (EAS), which is usually due to neuroendocrine tumors. In the present study we report our experience with EAS in eight patients evaluated and treated during the past 10 years. METHODS: Our experience in the evaluation and management of EAS was retrospectively reviewed. The latter included a standard biochemical assessment (urinary free cortisol, low- and high-dose dexamethasone suppression tests), petrosal sinus sampling when indicated and imaging techniques such as pituitary MRI, total body CT and somatostatin receptor scintigraphy. RESULTS: The ectopic nature of the ACTH hypersecretion was confirmed with inferior petrosal sinus samplings in all cases. CT scanning localized a putative tumor in 6/8 patients, whereas octreotide scintigraphy was positive in only five. In all cases, the source was traced to the lungs. However, upon performing thoracotomy, a documented ACTH-secreting bronchial carcinoid tumor was found in only four patients. Thus, 4/8 patients with EAS remained "occult." All of these patients underwent adrenalectomy for hypercortisolism control. CONCLUSIONS: EAS is a rare cause of ACTH-dependent Cushing's syndrome. Truly "occult" tumors were frequent and these patients need to be under close surveillance for the detection of neuroendocrine tumors.
机译:背景:区分两种依赖ACTH的库欣综合症是一项艰巨的任务。尽管这些病例中的大多数将被诊断为分泌ACTH的垂体腺瘤继发的库欣病,但10-15%的病因是异位ACTH分泌综合症(EAS),通常是由于神经内分泌肿瘤引起的。在本研究中,我们报告了在过去10年中接受评估和治疗的8例患者的EAS经验。方法:回顾性地回顾了我们在EAS评估和管理方面的经验。后者包括标准的生化评估(尿中游离皮质醇,低剂量和高剂量地塞米松抑制试验),指示时的岩窦采样以及影像学技术,例如垂体MRI,全身CT和生长抑素受体闪烁显像。结果:在所有病例中,下颌窦窦取样均证实了ACTH分泌过多的异位性质。 CT扫描在6/8位患者中发现了一个假定的肿瘤,而奥曲肽闪烁显像仅5例是阳性。在所有情况下,源均追溯到肺部。但是,在进行开胸手术后,仅四名患者发现了分泌ACTH的文献记载的支气管类癌。因此,仍有4/8例EAS患者保持“隐匿性”。所有这些患者均接受肾上腺切除术以控制皮质醇过多。结论:EAS是ACTH依赖性库欣综合症的罕见病因。真正的“隐匿性”肿瘤很常见,这些患者需要密切监视以检测神经内分泌肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号